{"id":"W3047382221","doi":"10.1016/j.euo.2020.07.002","title":"Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Enzalutamide; Taxane; Urology; Docetaxel; Adverse effect; Prostate-specific antigen; Internal medicine; Oncology; Cancer; Surgery; Androgen deprivation therapy; Breast cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000614826,0.001297049,0.001322611,0.0003083751,0.0003245246,0.0007586072,0.0007190504,0.00088102,0.004187128],"category_scores_gemma":[0.0003329621,0.0004198486,0.0009866214,0.0002482781,0.0008529458,0.0005326236,0.000319682,0.001975859,0.000828022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006956911,"about_ca_system_score_gemma":0.0009926708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001704668,"about_ca_topic_score_gemma":0.003493661,"domain_scores_codex":[0.9998416,0.00005759155,0.000004223036,0.0000302602,0.000009303264,0.00005712016],"domain_scores_gemma":[0.9997595,0.00002575933,0.00003218188,0.00001705858,0.000007415242,0.0001581278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8523171,0.0434211,0.002876308,0.0004704928,0.0008801405,0.0002036703,0.0001794845,0.002133349,0.02646302,0.0004980195,0.003526109,0.06703131],"study_design_scores_gemma":[0.6940627,0.2934106,0.006011992,0.00002063989,0.0003198243,0.0001845449,0.00006570199,0.001030501,0.002466035,0.0002440152,0.002158011,0.00002545028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927786,0.001893818,0.0004588114,0.0004748171,0.0001952582,0.0009145943,0.0006378278,0.0001638092,0.00248252],"genre_scores_gemma":[0.9900227,0.001435212,0.0009190519,0.0006019103,0.0001364982,0.0008119326,0.001558696,0.00002613744,0.004487834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004187128,"threshold_uncertainty_score":0.01400739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0444505241222058,"score_gpt":0.3321962393330813,"score_spread":0.2877457152108756,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}